VentriPoint Diagnostics Ltd.
VPTDF
$0.08
$0.00-3.22%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -95.90% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -95.90% | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -95.90% | -- | |||
| SG&A Expenses | -0.76% | -39.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.17% | -35.50% | |||
| Operating Income | -12.96% | 44.46% | |||
| Income Before Tax | 66.90% | 41.38% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 73.75% | 41.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 73.75% | 41.38% | |||
| EBIT | -12.96% | 44.46% | |||
| EBITDA | -12.97% | 44.48% | |||
| EPS Basic | 72.73% | 42.11% | |||
| Normalized Basic EPS | -19.05% | 41.67% | |||
| EPS Diluted | 72.73% | 42.11% | |||
| Normalized Diluted EPS | -19.05% | 41.67% | |||
| Average Basic Shares Outstanding | 0.44% | 2.17% | |||
| Average Diluted Shares Outstanding | 0.44% | 2.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||